The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
A bit of fun, late on Friday night
Who has the better odds?
England to win the soccer World Cup. Or Synairgen to get on a free trial?
Tick tock, tick tock, very soon the money stops
When the fun raise comes, the share price is done.
The price went up 12% today.
A nice punt fora day trader if you bought in at at 16’s.
People buying in for a potential RNS on Monday morning.
If there is no RNS on Monday morning the SP will fall back down to the 16’s during the week.
I repeat:
One single asset, zero trials, limited money.
Most small biotechs have multiple assets, drugs on trials and more money in the bank.
The facts do not look good for Synairgen.
But look on the bright side, you’ve got the world cup this weekend. I will be supporting your country in Qatar and even have a ticket to see them. I want either England or Italy to win. England have a better chance than Synairgen ;)
In America we say Hit a home run.
Any news yet?
Synairgen still don’t have a trial for their single asset?
Almost 11 months. Desperately seeking new platform trials at haste. One asset, not even a trial. New fund raise and 5p on its way, as predicted ;)
Hmmmmmm
Enjoy the soccer World Cup folks, your country has more chance of winning the World Cup than Synairgen have getting on a trial.
;)
Price heading towards 14/15 with zero news on the horizon for the foreseeable.
Then should go below 10 with the news of a new fund raise needed for survival.
It’s now been almost 10 solid months, zero news of Synairgen getting their single drug on to any trial.
This is unheard of within biotech circles.
A company with a single drug that hasn’t had their single drug on any trial for the last 10 months.
Is it the company to blame, or is it people talking on a message board that are to blame for such dismal performance?
Definition of the Synairgen zealot:
Someone who spends every day of their miserable life thinking about theories that could be happening with a tiny/irrelevant biotech research firm that has one product and doesn’t even have it on any trials.
The Synairgen zealot usually has this crazily optimistic belief that a company which has failed in the last 20 years to bring its single product to market is going to suddenly succeed.
Despite having this enthusiasm for the last two entire years and every single time it has ended in failure and disappointment, the Synairgen zealot still (for some bizarre reason) continues to put effort in to finding out theories or research to back up little ramps they have surrounding this irrelevant little company.
The Synairgen zealot fails to realise that if they had just put their money in Tesla or Bitcoin they would now be much better off.
In fact, had they put their money in Solana, pre pandemic, they would be sitting on heaps of riches right now.
But still they continue to believe that a useless failure of a CEO will somehow change his record of the last 20 years and magically create success.
It is now 10 months since Marsden said he was searching at haste to get Synairgen on to a free platform trial.
People were triumphantly and gleefully touting STRIVE as the platform trial for Synairgen, however this has proven to be false.
Thus, Synairgen are without a trial.
A biotech company with a single product, of which it hasn’t had any RND for the last 10 months.
Do people think Synairgen will get on a free platform trial, or do they think that they will have to do a fund raise to finance their own trial!
I’d say that given the length of time it has been since Marsden has been working at haste to find a free trial, it doesn’t look very likely this will be happening.
Almost certainly a fund raise will be needed in the future for the company to survive, let alone to start a P3 trial all over again.
Therefore I think 90% chance they need another fund raise to finance their own P3 trial. They can’t carry on for years and years without a product on the market without doing more fund raises, or they’ll just go bust.
Others on here will most likely say that a free platform trial is just around the corner (despite them saying that an RNS would be released in August saying that Synairgen was on the STRIVE trial, which never happened and indeed Synairgen is NOT on the STRIVE trial, albeit no one will pull up said posters that kept repeating STRIVE STRIVE STRIVE).
A drug can be ‘worthy’ of warranting extra trials due it being ‘promising’. However the problem arises when these extra trials cost a lot of money and NO ONE is willing to pay for these extra trials.
Normally with small biotech companies they pay for their own trials (as Synairgen did with their abysmal failure P3 trial).
Lost biotech companies have multiple drugs in various different phase trials, then generating a pipeline.
Synairgen has just one drug. It failed its P3 trial due to a monumental school boy error from whoever organised the trial, as a result the share price tanked 90%.
The education = trials don’t grow on trees. It is extremely unlikely that Synairgen will be offered a free platform trial, or a joint venture. Therefore they MUST FUND A TRIAL THEMSELVES if they are to bring their only potential drug to market.
It is looking ever more likely that a fund raise will be needed (some time next year) if they wish to take their interferons to market. They’ve spent 10 months begging for handouts and come to no avail.
Once the fund raise happens, the shares will be diluted a lot, reducing the share price to historic lows.
So, if this company is ever going to achieve anything and bring their interferons to market, then they are going to need to do a fund raise themselves, meaning historic low SP to come.
Three options:
1. The begging works, they get a free P3 trial, although it looks like clutching at straws right now.
2. They need to do a fund raise next year, SP goes to historic lows upon share dilution.
3. They go bust.
Those are your 3 options, nothings else that anyone says makes any difference at all, those three options are all that Synairgen have.
12p and below coming in 2023 when fund raise is needed.
We might see historical lows or folding of company.
Marsden must do a fund raise to get money to run the company.
Tik tok Tik tok, very soon the money stops,
When the fund raise come, the share price is done.
;)
Congrats on your 0% raise today you little Synairgen zealots frothing at the mouth.
Hmmm?
This forum was told back in June by quite a few of the rampers that there was going to be a new platform trial where Synairgen would be included.
As of yet, zero news on any new platform trial.
The cash runway is depleting.
Tik tok tik tok, I see the signs of fundraiser or bust.
So here is a little bit of reality, a reality that no one can deny:
If Synairgen do not have a product to market by the time their money (17 million) runs out, they either MUST do a fundraise, go bust or get bought out for tuppence.
Marsden has been frantically working at haste for 9 months now, yet has been totally unable to secure Synairgen’s place on any trial.
Hmmmm
What do you think the SP will be after a share solution and a new fundraise?
A great end to the day, getting closer to the new 12p price target I made.
I saw your prime minister Truss is on full valiant form today.
Well done Britain and Synairgen. Although Synairgen would probably be better off with Truss than Marsden.
Anyhow, 12p incoming
Drew
I reiterate the 12p price target this stock has.
With the wonderful ACTIV2 results announced yesterday the stock had a ‘huge boom’ of 6%, elevating it above 17p.
However the market doesn’t have any appetite for this company any more. The extremely slow time it takes them to get anything done has meant they’ve totally missed the boat for covid. Hence the markets dismal reaction and the new price target of 12p.
If you had invested when I advised to, at the 15p point, well done, you have collected 20% profit. Now wait until 12p to go for the punt.
Remember, this company do not have any upcoming trials, nor do they have the funding to pay for their own trial, this means ultimately a fund raise will be imminent for them to progress.
Research companies simply take money from shareholders, the current shareholders here are technically donators to help this research company, nothing more than that. Until this research company has a trial (and there will not be any government led platform trials, this is pure delusion, after nine months they would be on a trial by now if there was one available). Therefore Synairgen will have to do a fund raise in order to finance their own trial.
We saw what happened the last time Synairgen did their own P3 trial, so please be aware that this is a speculative punt at best.
1. Limited cash runway
2. Not enough cash for a trial
3. No platform trial available
4. Fund raise necessary in order to have a chance at progression to market
5. Failure in previous trial due to inexperienced and inadequate scientific elements and organisation of the P3 trial.
New target price 12p
San Diego. It was indeed.
That was before the SPRINTER calamity was released.
Look at the date on it.
Therefore after SPRINTER failure, this company’s single chance in its 25 year existence which they screwed up, it is now going to go back to historic lows again.
Next price target 12p.
Followed by another fund raise and share dilution.
5p incoming.
Btw, are you really that sad that you went back to January to find a quote from me?
Rofl This place is just hilarious.
Repeat after me:
‘SYNAIRGEN IS A TINY RESEARCH COMPANY THAT FAILED ITS ONLY CHANCE, I MUST STOP FOAMING AT THE MOUTH AND DREAMING THAT SYNAIRGEN WILL MAKE ME RICH, I AM DELUSIONAL AND MUST ACCEPT THAT SYNAIRGEN MISSED THEIR ONLY CHANCE’
Keep saying that a few times per day. Eventually the truth will sink in.
Then you either have nothing to do with this stock, or you trade this turkey like I am doing.
Andrewcapp, well done with your investment.
You bought in circa 150p and now it went up to 17p today.
Well done. Bravo. Well done Synairgen.
Keep waiting old son, keep waiting.
Or you can trade this turkey like I do and make some money.
Next target price = 12p.
Get ready for your glorious Synairgen (as you are one of the delusional Synairgen zealots foaming at the mouth believing that any day you will suddenly become a millionaire from this pathetically hopeless company).
One question for you.
When will you finally realise that this company is total garbage?
When will the realisation finally sink in that Synairgen are just a little research company with a CEO who has failed in twenty years? They took two years to test a covid drug and when results came out, they ruined their own trial and plummeted 90%.
When will that realisation finally get through your thick skull that this company is a turkey and is only good for trading?
Great news today, we ended the day 6.25% up and now are above 17p :)
If you bought in when I said, a few days ago, that’s now 18% profit you can take out.
Take the money out and wait for SP to tank down to 12p, then buy in again.